Deprecated: Required parameter $tempfile follows optional parameter $params in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/kingcomposer/includes/kc.tools.php on line 301

Deprecated: Required parameter $taxonomy follows optional parameter $parent in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/kingcomposer/includes/kc.ajax.php on line 1849

Deprecated: Required parameter $frame_val follows optional parameter $is in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/operations.class.php on line 656

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/operations.class.php on line 2858

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/operations.class.php on line 2862

Deprecated: Required parameter $slide follows optional parameter $publishedOnly in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/slider.class.php on line 2284

Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/output.class.php on line 3708

Deprecated: Required parameter $app_id follows optional parameter $item_count in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/external-sources.class.php on line 67

Deprecated: Required parameter $app_secret follows optional parameter $item_count in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/external-sources.class.php on line 67

Deprecated: Required parameter $app_id follows optional parameter $item_count in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/external-sources.class.php on line 89

Deprecated: Required parameter $app_secret follows optional parameter $item_count in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/external-sources.class.php on line 89

Deprecated: Required parameter $current_photoset follows optional parameter $item_count in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/revslider/includes/external-sources.class.php on line 1119

Deprecated: Required parameter $namespace follows optional parameter $directories in /var/www/vhosts/ekonomika.es/httpdocs/wp-content/plugins/theme_support_enduz/includes/vafpress/autoload.php on line 143
The Biotech Industry | Grupo EKonomiKa
  • Certificado de Calidad

    ISO 9001:2015 / ES-0395/2014
  • Grupo Líder

    En España

Javier Ramos

Biotech companies produce products that are beneficial to humans, such as medicines and therapies that can save lives, enhance yields on farms, and create sustainable chemicals and fuels. Bioinformatics is also a part of it, which is the study of biological processes and information. It is utilized in many different industries.

Biotech is a technology that has its roots in the early 1970s, when recombinant-DNA technology (genetic engineering) was invented and then patentable. This technique allows scientists to create production cells that then begin producing valuable protein molecules.

Biotechnology is extensively used in the target-discovery programs of a majority of pharmaceutical companies today. There are also small companies that employ unique techniques that are proprietary to create therapeutic drugs.

Other biotechnology-related applications are being explored by companies that focus on agro biology, cosmetics as well as the environment, food technology as well as industrial biotechnology and nutraceuticals and veterinary medicine. Fully integrated Pharma companies are massive, commercial enterprises that research and manufacture generic or brand-name drugs.

Biotech is changing due to new technologies. Companies can now validate their systems for conditions that have well-understood mechanisms, like sickle cell anemia, and reach broader patient populations. Certain companies are working to develop novel therapies for diseases that haven’t been addressed, such as Duchenne muscle dystrophy.

https://biotechworldwide.net/increasing-confidence-within-the-biotech-industry/